Controversial Vaccine Preservative To Be Discussed At Wednesday's CDC Meeting, Says National Autism Association
Tue, 20 Feb 2007 08:00 AM EST
... The Advisory Committee on Immunization Practices (ACIP) will meet this week at the CDC in Atlanta. Thimerosal, a controversial mercury-based vaccine preservative, is scheduled to be discussed Wednesday morning at 10:55 am. While thimerosal has been phased out of some vaccines, it is still present in flu shots recommended for pregnant women, infants and young children. [click link for full article] ...
Related Topics
- Autism
- MMR Vaccine & (Asceptic) Meningitis
- Vaccine
- Polio Vaccine & Cancer
- Polio Vaccine
- MMR Vaccine and Autism
- Polio Vaccine & Origin of HIV/AIDS
- Youth Sports & Recreational Programs
- Autism and Communication
- Vaccine Side Effects
- National Data
- Smallpox Vaccine
- Traffic Safety
- Chickenpox Vaccine
- MMWR
- Asphalt Paving & Roofing
- Hepatitis A Vaccine
- Hepatitis A and Hepatitis B Vaccine
- Palliative Care
- Hepatitis B Vaccine

Not Signed In -

